Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
Clinical trial NCT02553317 · COMPLETED
Trial details
- NCT number
- NCT02553317
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-08-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.